Research and Development Expense of RetinalGenix Technologies Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
Summary
RetinalGenix Technologies Inc. quarterly and annual Research and Development Expense in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • RetinalGenix Technologies Inc. Research and Development Expense for the quarter ending 30 Sep 2025 was $20,454, a 80% decline year-over-year.
  • RetinalGenix Technologies Inc. Research and Development Expense for the twelve months ending 30 Sep 2025 was $152,369.
  • RetinalGenix Technologies Inc. annual Research and Development Expense for 2024 was $373,271, a 29% decline from 2023.
  • RetinalGenix Technologies Inc. annual Research and Development Expense for 2023 was $524,183.
  • RetinalGenix Technologies Inc. annual Research and Development Expense for 2021 was $680,293, a 58% increase from 2020.
Source SEC data
View on sec.gov
Research and Development Expense, Trailing 12 Months (USD)
Research and Development Expense, Quarterly (USD)
Research and Development Expense, YoY Quarterly Change (%)
Research and Development Expense, Annual (USD)
Research and Development Expense, YoY Annual Change (%)

RetinalGenix Technologies Inc. Quarterly Research and Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $152,369 $20,454 -$82,523 -80% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $234,892 $14,430 -$68,496 -83% 01 Apr 2025 30 Jun 2025 10-Q/A 20 Aug 2025 2025 Q2
Q1 2025 $303,388 $13,214 -$69,883 -84% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $373,271 $104,271 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $102,977 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $82,926 -$69,651 -46% 01 Apr 2024 30 Jun 2024 10-Q/A 20 Aug 2025 2025 Q2
Q1 2024 $83,097 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q2 2023 $152,577 +$17,138 +13% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q2 2022 $608,560 $135,439 -$24,502 -15% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $633,062 $157,493 -$47,231 -23% 01 Jan 2022 31 Mar 2022 10-Q/A 16 May 2022 2022 Q1
Q4 2021 $680,293 $114,729 01 Oct 2021 31 Dec 2021 10-K 15 Apr 2022 2021 FY
Q3 2021 $200,899 +$102,003 +103% 01 Jul 2021 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 $159,941 01 Apr 2021 30 Jun 2021 10-Q 19 Aug 2022 2022 Q2
Q1 2021 $204,724 01 Jan 2021 31 Mar 2021 10-Q/A 16 May 2022 2022 Q1
Q3 2020 $98,896 01 Jul 2020 30 Sep 2020 10-Q 22 Nov 2021 2021 Q3

RetinalGenix Technologies Inc. Annual Research and Development Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $373,271 -$150,912 -29% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $524,183 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2021 $680,293 +$248,736 +58% 01 Jan 2021 31 Dec 2021 10-K 15 Apr 2022 2021 FY
2020 $431,557 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.